Economy
Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs
World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol
Published
Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider.
The world’s second largest brewer sent a presentation to British hospitality customers earlier this month warning that GLP-1 use – led by Ozempic and Wegovy – can reduce the desire to drink alcohol, which could lead to “fullness and fewer serves” of pints in pubs and bars.
